2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 27601593 | Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. | 2017 Mar 1 | 1 |
| 2 | 27701909 | Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia. | 2017 May | 1 |